Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Therapeutics: Myostatin (MSTN; GDF8)

Musculoskeletal disease

INDICATION: Muscular atrophy

Mouse studies suggest the anti-MSTN antibody NINA

Read the full 110 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE